Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kronos Bio Inc (KRON)

Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kronos Bio Inc 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 USA

www.kronosbio.com Employees: 63 P: 650-781-5200

Description:

Kronos Bio Inc. is a clinical-stage biopharmaceutical company. It engages in discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Kronos Bio Inc. is headquartered in San Mateo, Calif.

Key Statistics

Overview:

Market Capitalization, $K 51,893
Enterprise Value, $K -12,437
Shares Outstanding, K 60,341
Annual Sales, $ 6,290 K
Annual Net Income, $ -112,670 K
Last Quarter Sales, $ 2,370 K
Last Quarter Net Income, $ -14,110 K
EBIT, $ -93,070 K
EBITDA, $ -93,360 K
60-Month Beta 1.86
% of Insider Shareholders 24.40%
% of Institutional Shareholders 64.09%
Float, K 45,618
% Float 75.60%
Short Volume Ratio 0.10

Growth:

1-Year Return -25.27%
3-Year Return -93.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 11/13/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -1.43
EPS Growth vs. Prev Qtr 14.81%
EPS Growth vs. Prev Year 57.41%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KRON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -64.55%
Return-on-Assets % -48.18%
Profit Margin % -1,791.26%
Debt/Equity 0.00
Price/Sales 8.16
Price/Cash Flow N/A
Price/Book 0.46
Book Value/Share 1.84
Interest Coverage -1.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar